Six‐month oral clarithromycin regimen is safe and active in extranodal marginal zone B‐cell lymphomas: final results of a single‐centre phase II trial

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2010-07, Vol.150 (2), p.226-229
Hauptverfasser:	Govi, Silvia, Dognini, Giuseppina P., Licata, Giada, Crocchiolo, Roberto, Resti, Antonio Giordano, Ponzoni, Maurilio, Ferreri, Andrés J. M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antibiotics, Antineoplastic - therapeutic use anti‐neoplastic activity Biological and medical sciences clarithromycin Clarithromycin - therapeutic use conjunctival lymphoma Conjunctival Neoplasms - drug therapy extranodal marginal zone lymphoma Eye Neoplasms - drug therapy Feasibility Studies Female Hematologic and hematopoietic diseases Humans immunomodulator Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, B-Cell, Marginal Zone - drug therapy Male Medical sciences Middle Aged Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!